Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chromatin Assembly and Disassembly | 27 | 2023 | 629 | 7.150 |
Why?
|
Chromosomal Proteins, Non-Histone | 20 | 2024 | 723 | 6.370 |
Why?
|
Chromatin | 25 | 2023 | 2916 | 3.100 |
Why?
|
Transcription Factors | 37 | 2024 | 12060 | 2.840 |
Why?
|
Sarcoma, Synovial | 6 | 2021 | 150 | 2.510 |
Why?
|
Nucleosomes | 8 | 2023 | 481 | 1.940 |
Why?
|
Oncogene Proteins, Fusion | 8 | 2022 | 1572 | 1.760 |
Why?
|
Multiprotein Complexes | 6 | 2023 | 1114 | 1.350 |
Why?
|
Mammals | 10 | 2023 | 1127 | 1.320 |
Why?
|
Nuclear Proteins | 14 | 2023 | 5786 | 1.150 |
Why?
|
Rhabdoid Tumor | 2 | 2018 | 205 | 1.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 11 | 2024 | 8422 | 0.870 |
Why?
|
Disease | 2 | 2020 | 669 | 0.870 |
Why?
|
Neoplasm Proteins | 5 | 2020 | 3599 | 0.820 |
Why?
|
Liposarcoma, Myxoid | 1 | 2022 | 59 | 0.800 |
Why?
|
DNA-Binding Proteins | 11 | 2023 | 9551 | 0.740 |
Why?
|
Adenosine Triphosphatases | 3 | 2021 | 833 | 0.730 |
Why?
|
Heterochromatin | 3 | 2017 | 292 | 0.700 |
Why?
|
Histones | 6 | 2022 | 2566 | 0.670 |
Why?
|
Models, Molecular | 5 | 2022 | 5385 | 0.650 |
Why?
|
Ubiquitins | 1 | 2020 | 372 | 0.640 |
Why?
|
Proto-Oncogene Proteins | 4 | 2020 | 4474 | 0.630 |
Why?
|
Neoplasms | 11 | 2023 | 21808 | 0.620 |
Why?
|
HEK293 Cells | 8 | 2020 | 4220 | 0.610 |
Why?
|
Repressor Proteins | 3 | 2020 | 2973 | 0.610 |
Why?
|
Sarcoma | 3 | 2018 | 1788 | 0.610 |
Why?
|
Lymphoma | 6 | 2013 | 1887 | 0.590 |
Why?
|
Genetic Fitness | 1 | 2018 | 114 | 0.570 |
Why?
|
Lifting | 1 | 2016 | 55 | 0.520 |
Why?
|
Developmental Biology | 1 | 2016 | 77 | 0.520 |
Why?
|
Cell Line, Tumor | 18 | 2024 | 16736 | 0.520 |
Why?
|
Protein Subunits | 4 | 2021 | 944 | 0.500 |
Why?
|
p300-CBP Transcription Factors | 1 | 2016 | 150 | 0.500 |
Why?
|
Granulocytes | 1 | 2017 | 551 | 0.500 |
Why?
|
DNA Helicases | 7 | 2023 | 840 | 0.490 |
Why?
|
Meningeal Neoplasms | 2 | 2022 | 1232 | 0.490 |
Why?
|
Protein Interaction Mapping | 1 | 2018 | 617 | 0.470 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2016 | 302 | 0.450 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 2 | 2013 | 694 | 0.440 |
Why?
|
Meningioma | 1 | 2022 | 1209 | 0.440 |
Why?
|
Serine Endopeptidases | 1 | 2018 | 1017 | 0.430 |
Why?
|
Soft Tissue Neoplasms | 2 | 2020 | 1149 | 0.420 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2016 | 680 | 0.400 |
Why?
|
Complement Activation | 1 | 2013 | 444 | 0.390 |
Why?
|
Animals | 37 | 2024 | 166802 | 0.380 |
Why?
|
Protein Binding | 8 | 2021 | 9273 | 0.370 |
Why?
|
Central Nervous System Neoplasms | 3 | 2013 | 905 | 0.350 |
Why?
|
Mutation | 11 | 2023 | 29705 | 0.350 |
Why?
|
Genome, Human | 2 | 2019 | 4401 | 0.330 |
Why?
|
Enhancer Elements, Genetic | 4 | 2019 | 1338 | 0.320 |
Why?
|
Adenosine Triphosphate | 4 | 2022 | 1982 | 0.300 |
Why?
|
Hematopoiesis | 1 | 2017 | 2055 | 0.290 |
Why?
|
SOXB1 Transcription Factors | 2 | 2021 | 287 | 0.270 |
Why?
|
Humans | 57 | 2024 | 752341 | 0.250 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2017 | 2269 | 0.250 |
Why?
|
Lymphoma, Non-Hodgkin | 3 | 2012 | 1373 | 0.240 |
Why?
|
Octamer Transcription Factor-3 | 2 | 2024 | 224 | 0.240 |
Why?
|
Cell Proliferation | 6 | 2024 | 10358 | 0.230 |
Why?
|
RNA Interference | 4 | 2019 | 2843 | 0.210 |
Why?
|
Tumor Suppressor Proteins | 3 | 2020 | 2796 | 0.210 |
Why?
|
Oncogenes | 3 | 2021 | 1215 | 0.200 |
Why?
|
Virus Internalization | 2 | 2023 | 491 | 0.200 |
Why?
|
Liver Neoplasms | 1 | 2017 | 4271 | 0.200 |
Why?
|
Prostatic Neoplasms | 3 | 2018 | 11266 | 0.190 |
Why?
|
Mutation, Missense | 2 | 2020 | 2556 | 0.190 |
Why?
|
Gene Knockdown Techniques | 2 | 2018 | 1615 | 0.190 |
Why?
|
Genes, Tumor Suppressor | 2 | 2017 | 1056 | 0.190 |
Why?
|
Structural Homology, Protein | 1 | 2020 | 86 | 0.180 |
Why?
|
Histone Code | 1 | 2021 | 156 | 0.180 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2021 | 300 | 0.180 |
Why?
|
Brain Neoplasms | 4 | 2009 | 8892 | 0.170 |
Why?
|
Epidermal Growth Factor | 1 | 2022 | 691 | 0.170 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2024 | 415 | 0.170 |
Why?
|
DNA | 4 | 2022 | 7215 | 0.170 |
Why?
|
Gene Knockout Techniques | 2 | 2020 | 800 | 0.160 |
Why?
|
Spliceosomes | 1 | 2019 | 127 | 0.160 |
Why?
|
Genetic Predisposition to Disease | 2 | 2018 | 17648 | 0.160 |
Why?
|
Cyclin-Dependent Kinase 9 | 1 | 2018 | 67 | 0.160 |
Why?
|
Adenovirus E1A Proteins | 1 | 2018 | 73 | 0.160 |
Why?
|
Carcinoma, Medullary | 1 | 2019 | 115 | 0.160 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2013 | 9207 | 0.160 |
Why?
|
Wiskott-Aldrich Syndrome Protein | 1 | 2018 | 160 | 0.150 |
Why?
|
Brachytherapy | 1 | 2005 | 1241 | 0.150 |
Why?
|
Mutant Proteins | 1 | 2019 | 489 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2018 | 311 | 0.140 |
Why?
|
Catalysis | 1 | 2019 | 774 | 0.140 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2017 | 103 | 0.140 |
Why?
|
Genes, Essential | 1 | 2018 | 181 | 0.140 |
Why?
|
Transcriptional Activation | 1 | 2023 | 1751 | 0.140 |
Why?
|
Genetic Complementation Test | 1 | 2017 | 555 | 0.140 |
Why?
|
Cryoelectron Microscopy | 1 | 2020 | 628 | 0.140 |
Why?
|
Promoter Regions, Genetic | 2 | 2018 | 5782 | 0.140 |
Why?
|
Embryonic Stem Cells | 2 | 2021 | 1267 | 0.140 |
Why?
|
DNA Topoisomerases, Type II | 1 | 2017 | 121 | 0.140 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2017 | 232 | 0.130 |
Why?
|
Lymphoma, T-Cell | 1 | 2018 | 304 | 0.130 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2020 | 5163 | 0.130 |
Why?
|
RNA-Binding Protein EWS | 1 | 2017 | 209 | 0.130 |
Why?
|
Protein Conformation | 2 | 2022 | 3956 | 0.130 |
Why?
|
Mice | 15 | 2024 | 80543 | 0.130 |
Why?
|
Ubiquitination | 1 | 2020 | 1005 | 0.130 |
Why?
|
Transcription, Genetic | 3 | 2018 | 7576 | 0.120 |
Why?
|
RNA Splicing | 1 | 2019 | 911 | 0.120 |
Why?
|
Mutagenesis | 1 | 2018 | 1228 | 0.120 |
Why?
|
Complement C5b | 1 | 2013 | 9 | 0.120 |
Why?
|
Epigenesis, Genetic | 2 | 2018 | 3704 | 0.120 |
Why?
|
Histone Acetyltransferases | 1 | 2016 | 332 | 0.120 |
Why?
|
Rare Diseases | 1 | 2019 | 613 | 0.110 |
Why?
|
Complement C3a | 1 | 2013 | 66 | 0.110 |
Why?
|
Injections, Intraventricular | 1 | 2013 | 224 | 0.110 |
Why?
|
HeLa Cells | 1 | 2019 | 3086 | 0.110 |
Why?
|
Antibodies | 1 | 2021 | 2411 | 0.110 |
Why?
|
Chemokine CXCL13 | 1 | 2013 | 59 | 0.110 |
Why?
|
Injections, Spinal | 1 | 2013 | 312 | 0.110 |
Why?
|
Heterozygote | 1 | 2019 | 2785 | 0.110 |
Why?
|
RNA Polymerase II | 1 | 2016 | 537 | 0.100 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2019 | 1310 | 0.100 |
Why?
|
Organoids | 1 | 2018 | 715 | 0.100 |
Why?
|
Killer Cells, Natural | 1 | 2021 | 2174 | 0.100 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2013 | 325 | 0.100 |
Why?
|
Host-Pathogen Interactions | 1 | 2020 | 1439 | 0.100 |
Why?
|
Antineoplastic Agents | 2 | 2020 | 13553 | 0.100 |
Why?
|
Developmental Disabilities | 1 | 2020 | 1510 | 0.100 |
Why?
|
Receptors, Estrogen | 1 | 2020 | 2181 | 0.100 |
Why?
|
Phenotype | 2 | 2020 | 16439 | 0.100 |
Why?
|
Point Mutation | 1 | 2016 | 1591 | 0.100 |
Why?
|
Mass Spectrometry | 1 | 2018 | 2176 | 0.100 |
Why?
|
Drosophila | 1 | 2018 | 1491 | 0.090 |
Why?
|
DNA, Neoplasm | 1 | 2016 | 1741 | 0.090 |
Why?
|
Prostate | 1 | 2018 | 1784 | 0.090 |
Why?
|
Gene Expression Profiling | 3 | 2018 | 9355 | 0.090 |
Why?
|
DNA Replication | 1 | 2016 | 1406 | 0.090 |
Why?
|
Saccharomyces cerevisiae | 1 | 2020 | 2692 | 0.080 |
Why?
|
Binding Sites | 1 | 2018 | 6028 | 0.080 |
Why?
|
Tissue Distribution | 1 | 2013 | 2285 | 0.080 |
Why?
|
Lung Neoplasms | 2 | 2024 | 13165 | 0.080 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2782 | 0.080 |
Why?
|
Cell Cycle Proteins | 2 | 2020 | 3435 | 0.080 |
Why?
|
Mice, Inbred NOD | 3 | 2020 | 1809 | 0.080 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2012 | 636 | 0.080 |
Why?
|
STAT6 Transcription Factor | 1 | 2009 | 186 | 0.080 |
Why?
|
Recombinant Proteins | 1 | 2018 | 6509 | 0.080 |
Why?
|
Models, Genetic | 1 | 2019 | 3445 | 0.080 |
Why?
|
RNA-Binding Proteins | 1 | 2017 | 1894 | 0.080 |
Why?
|
Mice, Nude | 2 | 2019 | 3582 | 0.080 |
Why?
|
DNA Modification Methylases | 1 | 2009 | 205 | 0.080 |
Why?
|
Cell Nucleus | 1 | 2017 | 2904 | 0.080 |
Why?
|
Adenocarcinoma | 1 | 2005 | 6306 | 0.080 |
Why?
|
Protein Processing, Post-Translational | 1 | 2016 | 1953 | 0.080 |
Why?
|
DNA Methylation | 2 | 2019 | 4297 | 0.080 |
Why?
|
Amino Acid Sequence | 1 | 2019 | 13410 | 0.070 |
Why?
|
Interleukin-10 | 1 | 2013 | 1163 | 0.070 |
Why?
|
Luminescent Measurements | 1 | 2009 | 375 | 0.070 |
Why?
|
DNA Repair Enzymes | 1 | 2009 | 344 | 0.070 |
Why?
|
Gene Frequency | 1 | 2013 | 3586 | 0.070 |
Why?
|
Methotrexate | 1 | 2012 | 1702 | 0.070 |
Why?
|
Dacarbazine | 1 | 2009 | 560 | 0.070 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9465 | 0.070 |
Why?
|
Genomics | 2 | 2019 | 5727 | 0.060 |
Why?
|
Cell Polarity | 1 | 2009 | 636 | 0.060 |
Why?
|
Neoplasm Transplantation | 2 | 2019 | 2012 | 0.060 |
Why?
|
Interleukin-4 | 1 | 2009 | 1110 | 0.060 |
Why?
|
Proteins | 1 | 2020 | 6015 | 0.060 |
Why?
|
Genetic Testing | 1 | 2018 | 3505 | 0.060 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2020 | 2495 | 0.060 |
Why?
|
Antibodies, Monoclonal | 1 | 2020 | 9101 | 0.050 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2023 | 89 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2013 | 2821 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3066 | 0.050 |
Why?
|
Ethanol | 1 | 2009 | 1322 | 0.050 |
Why?
|
Prognosis | 3 | 2020 | 29327 | 0.050 |
Why?
|
Urinary Bladder | 1 | 2009 | 1169 | 0.050 |
Why?
|
Male | 11 | 2020 | 354881 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2019 | 4274 | 0.050 |
Why?
|
Signal Transduction | 3 | 2022 | 23233 | 0.050 |
Why?
|
Immunoblotting | 2 | 2020 | 1649 | 0.050 |
Why?
|
Proteomics | 2 | 2013 | 3750 | 0.050 |
Why?
|
Radiation Injuries | 1 | 2009 | 1180 | 0.050 |
Why?
|
Female | 13 | 2022 | 386053 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2020 | 12447 | 0.050 |
Why?
|
Liver Regeneration | 1 | 2022 | 213 | 0.050 |
Why?
|
Antibody Affinity | 1 | 2021 | 245 | 0.050 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2023 | 372 | 0.050 |
Why?
|
Genetic Markers | 1 | 2006 | 2605 | 0.040 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2020 | 3553 | 0.040 |
Why?
|
GPI-Linked Proteins | 1 | 2021 | 465 | 0.040 |
Why?
|
Vero Cells | 1 | 2020 | 483 | 0.040 |
Why?
|
Prostate-Specific Antigen | 2 | 2009 | 2524 | 0.040 |
Why?
|
Lymphoma, B-Cell | 2 | 2021 | 929 | 0.040 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2020 | 165 | 0.040 |
Why?
|
Treatment Failure | 1 | 2005 | 2635 | 0.040 |
Why?
|
HMGB1 Protein | 1 | 2020 | 139 | 0.040 |
Why?
|
GATA3 Transcription Factor | 1 | 2020 | 151 | 0.040 |
Why?
|
Haploinsufficiency | 1 | 2020 | 324 | 0.040 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 1 | 2018 | 104 | 0.040 |
Why?
|
Case-Control Studies | 4 | 2020 | 21841 | 0.040 |
Why?
|
Coronavirus | 1 | 2020 | 151 | 0.040 |
Why?
|
Azepines | 1 | 2020 | 323 | 0.040 |
Why?
|
Receptors, IgG | 1 | 2021 | 566 | 0.040 |
Why?
|
Guanosine Triphosphate | 1 | 2018 | 315 | 0.040 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2018 | 187 | 0.040 |
Why?
|
Genes, Dominant | 1 | 2020 | 865 | 0.040 |
Why?
|
Immunoprecipitation | 1 | 2020 | 875 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2020 | 3600 | 0.040 |
Why?
|
Immunoenzyme Techniques | 2 | 2013 | 1708 | 0.040 |
Why?
|
Cells, Cultured | 1 | 2013 | 18915 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2021 | 552 | 0.040 |
Why?
|
Electrophoresis, Agar Gel | 1 | 2017 | 214 | 0.040 |
Why?
|
Transcription Initiation Site | 1 | 2017 | 190 | 0.030 |
Why?
|
Histone Deacetylases | 1 | 2021 | 709 | 0.030 |
Why?
|
Alcohol Drinking | 1 | 2009 | 3991 | 0.030 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2018 | 614 | 0.030 |
Why?
|
Survival Rate | 3 | 2020 | 12746 | 0.030 |
Why?
|
Breast Neoplasms | 2 | 2021 | 20843 | 0.030 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2021 | 774 | 0.030 |
Why?
|
Antioxidants | 1 | 2023 | 1651 | 0.030 |
Why?
|
Microsatellite Repeats | 1 | 2017 | 789 | 0.030 |
Why?
|
Neuroglia | 1 | 2020 | 940 | 0.030 |
Why?
|
Aged, 80 and over | 3 | 2020 | 58300 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 2 | 2023 | 5594 | 0.030 |
Why?
|
Microscopy, Confocal | 1 | 2020 | 1976 | 0.030 |
Why?
|
Triazoles | 1 | 2020 | 906 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2018 | 871 | 0.030 |
Why?
|
Zebrafish Proteins | 1 | 2020 | 1003 | 0.030 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2017 | 867 | 0.030 |
Why?
|
Middle Aged | 7 | 2020 | 217019 | 0.030 |
Why?
|
Macrophages | 1 | 2009 | 5693 | 0.030 |
Why?
|
Ubiquitin | 1 | 2019 | 833 | 0.030 |
Why?
|
Rabbits | 1 | 2020 | 4761 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2005 | 8538 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2021 | 11883 | 0.030 |
Why?
|
Infusions, Intraventricular | 1 | 2012 | 33 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2018 | 990 | 0.030 |
Why?
|
Small Molecule Libraries | 1 | 2018 | 722 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2018 | 3078 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2018 | 1344 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2021 | 3124 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2018 | 3597 | 0.030 |
Why?
|
Gene Regulatory Networks | 1 | 2020 | 1712 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 2021 | 2818 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2018 | 1820 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2018 | 1480 | 0.020 |
Why?
|
Drosophila melanogaster | 1 | 2020 | 1700 | 0.020 |
Why?
|
Down-Regulation | 1 | 2018 | 2910 | 0.020 |
Why?
|
Drosophila Proteins | 1 | 2020 | 1696 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2021 | 2483 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 1987 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2016 | 1346 | 0.020 |
Why?
|
Cell Cycle | 1 | 2019 | 2928 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2019 | 2424 | 0.020 |
Why?
|
Gene Expression | 1 | 2023 | 7580 | 0.020 |
Why?
|
Epigenomics | 1 | 2016 | 927 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2016 | 1436 | 0.020 |
Why?
|
Chemotaxis | 1 | 2013 | 593 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14586 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2318 | 0.020 |
Why?
|
Sirolimus | 1 | 2017 | 1534 | 0.020 |
Why?
|
Adult | 5 | 2020 | 216913 | 0.020 |
Why?
|
Aged | 4 | 2020 | 166562 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 3448 | 0.020 |
Why?
|
Zebrafish | 1 | 2020 | 2995 | 0.020 |
Why?
|
Goserelin | 1 | 2009 | 127 | 0.020 |
Why?
|
Cell Survival | 1 | 2018 | 5771 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2018 | 2862 | 0.020 |
Why?
|
Infant | 2 | 2020 | 35673 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6501 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2016 | 1821 | 0.020 |
Why?
|
Mice, SCID | 1 | 2013 | 2617 | 0.020 |
Why?
|
Alleles | 1 | 2019 | 6879 | 0.020 |
Why?
|
Antithrombin III | 1 | 2007 | 129 | 0.020 |
Why?
|
Child, Preschool | 2 | 2020 | 41659 | 0.020 |
Why?
|
Genetic Loci | 1 | 2017 | 2602 | 0.020 |
Why?
|
Eye Neoplasms | 1 | 2009 | 307 | 0.020 |
Why?
|
Mesenchymal Stem Cells | 1 | 2017 | 1618 | 0.020 |
Why?
|
Fibroblasts | 1 | 2017 | 4056 | 0.020 |
Why?
|
Cell Line | 1 | 2020 | 15633 | 0.020 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2007 | 179 | 0.020 |
Why?
|
Drug Therapy | 1 | 2009 | 499 | 0.020 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2007 | 494 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4572 | 0.020 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2009 | 553 | 0.020 |
Why?
|
Blotting, Western | 1 | 2013 | 5035 | 0.020 |
Why?
|
Genetic Variation | 1 | 2020 | 6507 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2013 | 6137 | 0.020 |
Why?
|
Adolescent | 3 | 2020 | 86765 | 0.020 |
Why?
|
Leukemia, Myeloid | 1 | 2007 | 695 | 0.010 |
Why?
|
Chromatography, Liquid | 1 | 2007 | 978 | 0.010 |
Why?
|
Recurrence | 1 | 2016 | 8420 | 0.010 |
Why?
|
Kidney | 1 | 2019 | 6983 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10690 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2021 | 19894 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2009 | 12898 | 0.010 |
Why?
|
Salvage Therapy | 1 | 2009 | 1265 | 0.010 |
Why?
|
Radiotherapy | 1 | 2009 | 1506 | 0.010 |
Why?
|
Child | 2 | 2020 | 78998 | 0.010 |
Why?
|
Neurons | 1 | 2020 | 9351 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10036 | 0.010 |
Why?
|
Pregnancy | 1 | 2022 | 29439 | 0.010 |
Why?
|
Stem Cell Transplantation | 1 | 2009 | 1600 | 0.010 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2009 | 1519 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3781 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2018 | 21712 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39079 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2013 | 12738 | 0.010 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2007 | 1395 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 40984 | 0.010 |
Why?
|
Time Factors | 1 | 2017 | 39854 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 57629 | 0.010 |
Why?
|
Immunotherapy | 1 | 2009 | 4601 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2009 | 20348 | 0.000 |
Why?
|
Risk Factors | 1 | 2009 | 73412 | 0.000 |
Why?
|